Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Snowdon
AddedFeb 16, 2024
UpdatedJun 18, 2026
Snowdon

Snowdon

Public

Snowdon Inc., a US-based pharmaceutical company, focuses on developing safe, effective drugs for pain, neurological disorders, and infectious diseases.

HQ
Jersey City, NJ, US
Founded
2005
Overview
Compare
Fundraising
Employees

Snowdon Inc., based in Princeton, United States, is a pharmaceutical company dedicated to developing safe and effective drugs for acute and chronic pain, neurological disorders, and infectious diseases. The company aims to address significant medical needs and improve the quality of life for millions affected by these conditions.

Snowdon has achieved notable progress in its drug discovery pipeline, with several promising candidates targeting these critical therapeutic areas. The company's innovative approach has the potential to make a substantial impact on global health, alleviating suffering and reducing economic burdens associated with these diseases.

Snowdon - Similar Companies

NeuroTherapeutics Pharma logo

NeuroTherapeutics Pharma

Supernus Pharmaceuticals logo

Supernus Pharmaceuticals

supernus.com

Exodos Life Sciences logo

Exodos Life Sciences

exodosls.com

Solace Pharmaceuticals logo

Solace Pharmaceuticals

Caden Biosciences logo

Caden Biosciences

Pono Pharma logo

Pono Pharma

Xdynia logo

Xdynia

Aptinyx logo

Aptinyx

aptinyx.com

Woolsey Pharmaceuticals logo

Woolsey Pharmaceuticals

woolseypharma.com

NeuroGenetic Pharmaceuticals logo

NeuroGenetic Pharmaceuticals

Scienture logo

Scienture

scienture.com

Edison Pharmaceuticals logo

Edison Pharmaceuticals

Intellect Neurosciences logo

Intellect Neurosciences

NeuroPro Therapeutics logo

NeuroPro Therapeutics

PleoPharma logo

PleoPharma

pleopharma.com

Snowdon - Quick Facts

Who are Snowdon's competitors?

Companies similar to Snowdon include NeuroTherapeutics Pharma, Supernus Pharmaceuticals, Exodos Life Sciences and Solace Pharmaceuticals.

When was Snowdon founded?

Snowdon was founded in 2005.

Where is Snowdon's headquarters located?

Snowdon's headquarters is located in Jersey City, NJ, US.

When was Snowdon's last funding round?

Snowdon's most recent funding round was for $500k (USD) in March 2007.

How much has Snowdon raised to-date?

As of Mar 22, 2007, Snowdon has raised a total of $500k (USD).

How many employees does Snowdon have?

Snowdon has 4 employees as of Feb 4, 2024.

Snowdon - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
  • Government
Main Product
  • Drugs
  • Pharmaceuticals
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
Show 13 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research